Theravance Biopharma Inc share price logo

Theravance Biopharma Inc Share Price

NASDAQ: TBPH

Small Cap

$14.40

+0.10

(+0.70%)

as on

Theravance Biopharma Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    $13.88
    $14.4
    downward going graph

    3.61%

    Downside

  • 52 Week's Low

    52 Week's High

    $7.88
    $14.55
    downward going graph

    45.28%

    Downside

    1.04%

    Upside

    downward going graph

Theravance Biopharma Inc share price movements today

Previous Close
$14.30
Open
$14.27
Volume
495.2K
Day's Low - High
$13.88 - $14.4
52 Week Low - High
$7.88 - $14.55

Theravance Biopharma Inc Historical Returns

1 Month Return
+ 8.75 %
3 Month Return
+ 33.77 %
1 Year Return
+ 75.68 %
3 Year Return
+ 42.29 %
5 Year Return
-19.8 %

Theravance Biopharma Inc Stock Fundamentals & Key Indicators

Check Theravance Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$720.2M

EPS (TTM)

-0.15

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

59.58

Industry PE ratio

-3.8535542168674697

P/B Ratio

59.5833

PEG Ratio

-0.05

EBITDA

-34.0M

Revenue (TTM)

77.2M

Profit Margin

16.88%

Return On Equity TTM

6.23%

Theravance Biopharma Inc Stock Valuation

Track how Theravance Biopharma Inc P/E has moved over time to understand its valuation trends.

Theravance Biopharma Inc in the last 5 years

  • Overview

  • Trends

Lowest (24.89x)

June 30, 2025

Industry (-3.85x)

September 15, 2025

Today (59.58x)

September 15, 2025

Highest (24.89x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 59.58x

Theravance Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Theravance Biopharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$720.2M-19.8%59.5816.88%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Theravance Biopharma Inc Stock including INR - Dollar returns

The Theravance Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Theravance Biopharma Inc investment value today

Current value as on today

₹1,81,890

Returns

₹81,890

(+81.89%)

Returns from Theravance Biopharma Inc Stock

₹76,904 (+76.9%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Theravance Biopharma Inc Stock

Based on 11 analysts

BUY

72.73%

Buy

27.27%

Hold

0.00%

Sell

Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Theravance Biopharma Inc. Average target price of $20

Theravance Biopharma Inc Share Price Target

Get share price movements and forecasts by analysts on Theravance Biopharma Inc.

What analysts predicted

28%UPSIDE

Target Price

$20

Current Price

$14.4

Analyzed by

11 Analysts

Target

$20.00

Theravance Biopharma Inc target price $20, a slight upside of 28% compared to current price of $14.4. According to 11 analysts rating.

Theravance Biopharma Inc Stock's Interest Amongst Investors

Search interest for Theravance Biopharma Inc Stock has increased by 50% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:50% versus previous 30 day period

Theravance Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
10
13
15
17
14
14
16
18
15
26
Gross Profit
8
12
14
13
14
14
16
18
15
26
Operating Income
-24
-16
-8
-6
-11
-15
-10
-9
-14
-2
EBITDA
-20
-12
-5
-2
-8
-13
-8
-7
-12
74
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
1
1
0
0
0
1
0
Income Before Tax
-22
-14
-7
-5
-10
-15
-10
-8
-14
73
Income Tax Expense
0
1
1
3
1
1
2
6
0
18
Net Income
-22
-15
-8
-8
-11
-16
-12
-15
-13
54
Net Profit Margin
-212.04%
-113.79%
-57.03%
-48.45%
-80.42%
-115.94%
-75.28%
-82.79%
-88.24%
209.33%

Theravance Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
42
48
15
60
73
71
55
51
57
64
Gross Profit
37
45
9
59
-145
-189
48
44
57
64
Operating Income
-181
-180
-260
-238
-251
-297
-257
-91
-56
-46
EBITDA
-178
-176
-259
-212
-203
-293
-249
-79
-42
-38
Interest Expense
0
1
8
10
31
44
8
6
2
2
Depreciation
-
-
4
3
6
9
9
7
4
3
Income Before Tax
-181
-180
-271
-226
-241
-286
-199
-92
-49
-44
Income Tax Expense
0
10
13
-10
-5
-8
0
0
5
11
Net Income
-182
-190
-285
-215
-236
-278
-199
-92
-55
-56
Net Profit Margin
-432.56%
-391.94%
-1854.97%
-357.01%
-322.08%
-386.90%
-360.55%
-180.78%
-96.11%
-87.63%

Theravance Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-15
-8
-8
-11
-16
-12
-15
-13
54
Operating Cash Flow
-12
-2
0
-1
-4
-5
0
43
208
Investing Cash Flow
11
0
0
17
-3
-17
15
30
-36
Financing Cash Flow
-80
-31
-30
-1
0
0
0
0
0
Change in Cash
-82
-33
-32
14
-7
-22
14
72
171

Theravance Biopharma Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-190
-285
-215
-236
-278
-199
-92
-55
-56
Operating Cash Flow
-98
-201
-112
-238
-250
-207
-186
-26
-11
Investing Cash Flow
-148
-56
176
-83
10
124
1,154
-32
12
Financing Cash Flow
479
1
225
1
263
91
-758
-198
-2
Change in Cash
232
-255
289
-319
23
8
208
-258
-1

Global Institutional Holdings in Theravance Biopharma Inc

Funds
Holdings
Madison Avenue Partners, LP
19.02%
Weiss Asset Management LP
14.91%
Newtyn Management LLC
9.51%
BlackRock Inc
6.9%
Irenic Capital Management LP
5.52%

Insights on Theravance Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, TBPH has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, TBPH stock has moved up by 33.8%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 15.38M → 26.19M (in $), with an average increase of 41.3% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -15.52M → 54.83M (in $), with an average increase of 69.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 81.2%

About Theravance Biopharma Inc

theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.
OrganisationTheravance Biopharma Inc
Headquarters901 Gateway Boulevard, South San Francisco, CA, United States, 94080
IndustryHealth Technology
CEOMr. Rick E. Winningham M.B.A.
E-voting on sharesClick here to vote

Key Management of Theravance Biopharma Inc

Name

Title

Mr. Stuart Knight

Senior VP of IT&I and Chief Information Officer

Ms. Rhonda F. Farnum

Chief Business Officer and Senior VP of Commercial & Medical Affairs

Ms. Stacy L. Pryce

Senior VP & Chief Strategy Officer

Dr. Aine Miller Ph.D.

Senior VP of Development & Head of Ireland Office

Mr. Rick E. Winningham M.B.A.

CEO & Director

Mr. Aziz Sawaf C.F.A.

Senior VP & CFO

Mr. Brett A. Grimaud Esq.

Senior VP, General Counsel & Secretary

FAQs

What is Theravance Biopharma Inc share price today?

Theravance Biopharma Inc share price today is $14.4 as on at the close of the market. Theravance Biopharma Inc share today touched a day high of $14.4 and a low of $13.88.

What is the 52 week high and 52 week low for Theravance Biopharma Inc share?

Theravance Biopharma Inc share touched a 52 week high of $14.55 on and a 52 week low of $7.88 on . Theravance Biopharma Inc stock price today i.e. is closed at $14.4,which is 1.03% down from its 52 week high and 82.74% up from its 52 week low.

What is Theravance Biopharma Inc's market capitalisation today?

Theravance Biopharma Inc market capitalisation is $0.00T as on .

How to invest in Theravance Biopharma Inc Stock (TBPH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Theravance Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Theravance Biopharma Inc Shares that will get you 0.1042 shares as per Theravance Biopharma Inc share price of $14.4 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Theravance Biopharma Inc Stock (TBPH) from India?

Indian investors can start investing in Theravance Biopharma Inc (TBPH) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Theravance Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Theravance Biopharma Inc share’s latest price of $14.4 as on September 16, 2025 at 1:29 am IST, you will get 0.6944 shares of Theravance Biopharma Inc. Learn more about fractional shares .

What are the returns that Theravance Biopharma Inc has given to Indian investors in the last 5 years?

Theravance Biopharma Inc stock has given -19.8% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?